NCT03341689: Psilocybin for the Treatment of Migraine Headache
- State
- Completed
- Phase
- Phase 1
- People
- 14 taking part
- Started
- 1 Nov 2017
- Primary completion
- 30 Apr 2021
- Arms
- Placebo/Low Dose Psilocybin, Placebo/High Dose Psilocybin, Low Dose Psilocybin/Placebo, High Dose Psilocybin/Placebo
- Results
- None posted
- 1 Nov 2017: Trial started
- 14 Nov 2017: Trial registered
- 31 Oct 2021: Trial completed